{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:14:16Z","timestamp":1778739256991,"version":"3.51.4"},"reference-count":166,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Emerging Drugs"],"published-print":{"date-parts":[[2025,10,2]]},"DOI":"10.1080\/14728214.2026.2650178","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T08:51:23Z","timestamp":1774255883000},"page":"263-281","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the latest emerging drugs for the treatment of sickle cell disease"],"prefix":"10.1080","volume":"30","author":[{"given":"Giovanna","family":"Cannas","sequence":"first","affiliation":[{"name":"Edouard Herriot Hospital","place":["Lyon, France"]},{"name":"Constitutive Reference Center: Major Sickle Cell Syndromes, Thalassemia and Other Rare Pathologies of Red Blood Cell and Erythropoiesis, Edouard Herriot Hospital, Pole Medical","place":["Lyon, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510865"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2020.08.009"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199611000-00002"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1715971"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611770"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903212"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004394C"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2017.05.009"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-2-200801150-00004"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0000000000000289"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13430"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/PSY.0b013e31815ff5c5"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.143.8.1024"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001851"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1515\/sjpain-2017-0140"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16273"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043900"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.757718"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201207-1222OC"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201510-706OC"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.4530"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00272-2018"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-012-9435-3"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.113.001420"},{"key":"e_1_3_4_28_1","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong K","year":"1998","unstructured":"Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91:288\u2013294.","journal-title":"Blood"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-599852"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70469-0"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807023390102"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2002.122498"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25390"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07830719"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24810"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25614"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24100"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft295"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12024"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16113"},{"key":"e_1_3_4_41_1","first-page":"Cd010858","article-title":"Vitamin D supplementation for sickle cell disease","volume":"1","author":"Soe HH","year":"2017","unstructured":"Soe HH, Abas AB, Than NN, et al. Vitamin D supplementation for sickle cell disease. Cochrane Database Syst Rev. 2017;1:Cd010858.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025015822"},{"key":"e_1_3_4_43_1","first-page":"e24920","article-title":"Comparing the safety and efficacy of L-glutamine, voxelotor, and crizanlizumab for reducing the frequency of vaso-occlusive crisis in sickle cell disease: a systematic review","author":"Dick MH","year":"2022","unstructured":"Dick MH, Abdelgadir A, Kulkami V, et al. Comparing the safety and efficacy of L-glutamine, voxelotor, and crizanlizumab for reducing the frequency of vaso-occlusive crisis in sickle cell disease: a systematic review. Cureus. 2022:e24920.","journal-title":"Cureus"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1055540"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2020.08.008"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy10050123"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01041-7"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2022.2044509"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.13.1645"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2002.121383"},{"key":"e_1_3_4_51_1","first-page":"482","volume-title":"Measuring success: utility of biomarkers in sickle cell disease clinical trials and care","author":"Kalpatthi R","year":"2018","unstructured":"Kalpatthi R, Novelli EM. Measuring success: utility of biomarkers in sickle cell disease clinical trials and care. Vol. 2018. ASH Hematol Educ Progr; 2018. p. 482\u2013492."},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000002519"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-022-04867-y"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1177\/1535370219900637"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-05736-6"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00384-3"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-1198"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-179042"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.6b00491"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012070"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26485"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16225"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.4103\/ajts.AJTS_36_18"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2021000307"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2014.08.014"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-745711"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30154-1"},{"issue":"2","key":"e_1_3_4_68_1","first-page":"100","article-title":"Barriers to bone marrow transplantation for sickle cell anemia","volume":"2","author":"Walters MC","year":"1996","unstructured":"Walters MC, Patience M, Leisenning W, et al. Barriers to bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transpl. 1996;2(2):100\u2013104.","journal-title":"Biol Blood Marrow Transpl"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30031-6"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.11.027"},{"key":"e_1_3_4_71_1","first-page":"1918","article-title":"Epeleuton, a novel synthetic \u03ce-3 fatty acid, reduces hypoxia\/reperfusion stress in a mouse model of sickle cell disease","volume":"109","author":"Matte A","year":"2024","unstructured":"Matte A, Federti E, Recchiuti A, et al. Epeleuton, a novel synthetic \u03ce-3 fatty acid, reduces hypoxia\/reperfusion stress in a mouse model of sickle cell disease. Haematologica. 2024;109:1918\u20131932.","journal-title":"Haematologica"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-188727"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19111"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000848800.77383.3d"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-140530"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-023-03514-3"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-04-084061"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2020.102481"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2024.09.051"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-4728"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.70028"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2025.2489123"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2022.1994945"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77171-2"},{"issue":"1","key":"e_1_3_4_85_1","first-page":"73","article-title":"ILX-002 a direct HbS polymerization inhibitor for the treatment of sickle cell disease","volume":"1","author":"Abdulmalik O","year":"2024","unstructured":"Abdulmalik O, Fleischman AN, Light DR, et al. ILX-002 a direct HbS polymerization inhibitor for the treatment of sickle cell disease. J Sickle Cell Dis. 2024;1(suppl.1):73\u201374.","journal-title":"J Sickle Cell Dis"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-2932"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1039\/C5OB00367A"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph18060783"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023011477"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.109"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015403"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.284831"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00319-3"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.121.000743"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023012467"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-204962"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-203509"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.70048"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI89741"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.086637"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27692"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-616"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05625.x"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-306167"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00045-0"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.02990.x"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2007.02.043"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07027.x"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14009"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002382"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-169283"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24019"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-02-0454"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23533"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23725"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-1157"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-319137"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2021.102561"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-11-465963"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017009613"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171067"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-200182"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-2975"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-838"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-130036"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-142477"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.4173.4173"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16343"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S287301"},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-166694"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11030630"},{"issue":"1","key":"e_1_3_4_132_1","first-page":"5","article-title":"Phase 1 study of the safety and pharmacokinetics of CSL889 (hemopexin) in adults with SCD","volume":"1","author":"Shore PM","year":"2024","unstructured":"Shore PM, Biemond BJ, Kesse-Adu R, et al. Phase 1 study of the safety and pharmacokinetics of CSL889 (hemopexin) in adults with SCD. J Sickle Cell Dis. 2024;1(suppl.1):5\u20136.","journal-title":"J Sickle Cell Dis"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205194"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-615"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609677"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003776"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.236182"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26371"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109167"},{"key":"e_1_3_4_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2024.101185"},{"key":"e_1_3_4_141_1","doi-asserted-by":"publisher","DOI":"10.1089\/crispr.2024.0101"},{"key":"e_1_3_4_142_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1630994"},{"key":"e_1_3_4_143_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-022124-022000"},{"key":"e_1_3_4_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2024.11.006"},{"key":"e_1_3_4_145_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2117175"},{"key":"e_1_3_4_146_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05294-3"},{"key":"e_1_3_4_147_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011488"},{"key":"e_1_3_4_148_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017960"},{"key":"e_1_3_4_149_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells11111843"},{"key":"e_1_3_4_150_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2031054"},{"key":"e_1_3_4_151_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018252"},{"key":"e_1_3_4_152_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000967968.05170.e0"},{"key":"e_1_3_4_153_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2029392"},{"key":"e_1_3_4_154_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-02-765891"},{"key":"e_1_3_4_155_1","volume-title":"Characteristics of inpatient hospital stays involving sickle cell disease, 2000\u20132016: statistical brief # 251. Healthcare cost and utilization project (HCUP) statistical briefs","author":"Fingar KR","year":"2019","unstructured":"Fingar KR, Owens PL, Reid LD, et al. Characteristics of inpatient hospital stays involving sickle cell disease, 2000\u20132016: statistical brief # 251. Healthcare cost and utilization project (HCUP) statistical briefs. Rockville (MD): Agency for Healthcare Research and Quality; 2019 Sep 3."},{"key":"e_1_3_4_156_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015797"},{"key":"e_1_3_4_157_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12604"},{"key":"e_1_3_4_158_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.993.993"},{"key":"e_1_3_4_159_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013674"},{"key":"e_1_3_4_160_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512021"},{"key":"e_1_3_4_161_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2013.08.002"},{"key":"e_1_3_4_162_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08520.x"},{"key":"e_1_3_4_163_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21033"},{"key":"e_1_3_4_164_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26956"},{"key":"e_1_3_4_165_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01257-y"},{"key":"e_1_3_4_166_1","doi-asserted-by":"publisher","DOI":"10.3906\/biy-1912-52"},{"key":"e_1_3_4_167_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2024.01.015"},{"key":"e_1_3_4_168_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21443"}],"container-title":["Expert Opinion on Emerging Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14728214.2026.2650178","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:45:18Z","timestamp":1778737518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14728214.2026.2650178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":166,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10,2]]}},"alternative-id":["10.1080\/14728214.2026.2650178"],"URL":"https:\/\/doi.org\/10.1080\/14728214.2026.2650178","relation":{},"ISSN":["1472-8214","1744-7623"],"issn-type":[{"value":"1472-8214","type":"print"},{"value":"1744-7623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}